NLS Pharmaceutics Ltd. (NASDAQ:NLSP – Get Free Report) shares dropped 0.4% on Wednesday . The stock traded as low as $2.20 and last traded at $2.28. Approximately 108,799 shares traded hands during mid-day trading, a decline of 98% from the average daily volume of 4,439,447 shares. The stock had previously closed at $2.29.
NLS Pharmaceutics Price Performance
The firm’s 50-day moving average price is $2.08 and its two-hundred day moving average price is $2.25.
NLS Pharmaceutics Company Profile
NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).
See Also
- Five stocks we like better than NLS Pharmaceutics
- With Risk Tolerance, One Size Does Not Fit All
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Transportation Stocks Investing
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for NLS Pharmaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NLS Pharmaceutics and related companies with MarketBeat.com's FREE daily email newsletter.
